Tct (bvi) Limited - Net Worth and Insider Trading
Tct (bvi) Limited Net Worth
The estimated net worth of Tct (bvi) Limited is at least $185 Million dollars as of 2024-09-24. Tct (bvi) Limited is the 2501 Other of Fusen Pharmaceutical Co Ltd and owns about 185,180,000 shares of Fusen Pharmaceutical Co Ltd (HKSE:01652) stock worth over $185 Million. Details can be seen in Tct (bvi) Limited's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tct (bvi) Limited has not made any transactions after 2022-07-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Tct (bvi) Limited
Tct (bvi) Limited Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tct (bvi) Limited owns 1 companies in total, including Fusen Pharmaceutical Co Ltd (HKSE:01652) .
Click here to see the complete history of Tct (bvi) Limited’s form 4 insider trades.
Insider Ownership Summary of Tct (bvi) Limited
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:01652 | Fusen Pharmaceutical Co Ltd | 2022-07-29 | 2501 Other |
Tct (bvi) Limited Latest Holdings Summary
Tct (bvi) Limited currently owns a total of 1 stock. Tct (bvi) Limited owns 185,180,000 shares of Fusen Pharmaceutical Co Ltd (HKSE:01652) as of July 29, 2022, with a value of $185 Million.
Latest Holdings of Tct (bvi) Limited
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:01652 | Fusen Pharmaceutical Co Ltd | 2022-07-29 | 185,180,000 | 1.00 | 185,180,000 |
Holding Weightings of Tct (bvi) Limited
Tct (bvi) Limited Form 4 Trading Tracker
According to the SEC Form 4 filings, Tct (bvi) Limited has made a total of 2 transactions in Fusen Pharmaceutical Co Ltd (HKSE:01652) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Fusen Pharmaceutical Co Ltd is the sale of 5,000,000 shares on July 29, 2022, which brought Tct (bvi) Limited around $0.
Insider Trading History of Tct (bvi) Limited
- 1
Tct (bvi) Limited Trading Performance
Tct (bvi) Limited Ownership Network
Tct (bvi) Limited Owned Company Details
What does Fusen Pharmaceutical Co Ltd do?
Who are the key executives at Fusen Pharmaceutical Co Ltd?
Tct (bvi) Limited is the 2501 Other of Fusen Pharmaceutical Co Ltd. Other key executives at Fusen Pharmaceutical Co Ltd include 2201 Interest of corporation controlled by you Cao Changcheng , 2202 Interest of your spouse Quan Xiufeng , and 2101 Beneficial owner Full Bliss Holdings Limited .
Fusen Pharmaceutical Co Ltd (HKSE:01652) Insider Trades Summary
Over the past 18 months, Tct (bvi) Limited made no insider transaction in Fusen Pharmaceutical Co Ltd (HKSE:01652). Other recent insider transactions involving Fusen Pharmaceutical Co Ltd (HKSE:01652) include a net purchase of 2,412,000 shares made by Cao Changcheng , a net purchase of 2,412,000 shares made by Quan Xiufeng , and a net purchase of 1,308,000 shares made by Cao Zhiming .
In summary, during the past 3 months, insiders sold 0 shares of Fusen Pharmaceutical Co Ltd (HKSE:01652) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Fusen Pharmaceutical Co Ltd (HKSE:01652) were sold and 9,852,000 shares were bought by its insiders, resulting in a net purchase of 9,852,000 shares.
Fusen Pharmaceutical Co Ltd (HKSE:01652)'s detailed insider trading history can be found in Insider Trading Tracker table.
Fusen Pharmaceutical Co Ltd Insider Transactions
Tct (bvi) Limited Mailing Address
Above is the net worth, insider trading, and ownership report for Tct (bvi) Limited. Currently GuruFocus does not have mailing address information for Tct (bvi) Limited.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
